These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35603151)
1. Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Xu Y; Du Y; Zheng Q; Zhou T; Ye B; Wu Y; Xu Q; Meng X Front Immunol; 2022; 13():895110. PubMed ID: 35603151 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma. Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859 [TBL] [Abstract][Full Text] [Related]
3. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
4. A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer. Zhang Y; Liang Y; Wang Y; Ye F; Kong X; Yang Q Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36222299 [TBL] [Abstract][Full Text] [Related]
5. A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer. Ke ZB; You Q; Sun JB; Zhu JM; Li XD; Chen DN; Su L; Zheng QS; Wei Y; Xue XY; Xu N Front Cell Dev Biol; 2021; 9():774625. PubMed ID: 35071228 [No Abstract] [Full Text] [Related]
6. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer. Wang Y; Xu Y; Zhang Y Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765 [TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma. Yang L; Fan X; Zhou C; Wang Z; Cui Z; Wu X; Xu Z; Yang J; Zhang X Transl Lung Cancer Res; 2023 Aug; 12(8):1766-1781. PubMed ID: 37691861 [TBL] [Abstract][Full Text] [Related]
8. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma. Xu L; Zheng Q; Liu W BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323 [TBL] [Abstract][Full Text] [Related]
9. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma. Sae-Fung A; Mutirangura A; Jitkaew S Front Immunol; 2022; 13():1051273. PubMed ID: 36733386 [TBL] [Abstract][Full Text] [Related]
11. A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer. Zhang J; Wang X; Zhang Z; Ma F; Wang F Sci Rep; 2024 Mar; 14(1):5339. PubMed ID: 38438469 [TBL] [Abstract][Full Text] [Related]
12. Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer. Hao S; Yang Z; Wang G; Cai G; Qin Y BMC Cancer; 2024 Aug; 24(1):958. PubMed ID: 39107713 [TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma. Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y Front Surg; 2022; 9():860806. PubMed ID: 35937602 [TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C Front Immunol; 2021; 12():783362. PubMed ID: 35154072 [TBL] [Abstract][Full Text] [Related]
15. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients. Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038 [TBL] [Abstract][Full Text] [Related]
16. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer. Li XF; Fu WF; Zhang J; Song CG BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369 [TBL] [Abstract][Full Text] [Related]
17. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer. Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989 [TBL] [Abstract][Full Text] [Related]
18. Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes. Wang N; Gu Y; Li L; Chi J; Liu X; Xiong Y; Jiang S; Zhang W; Zhong C Sci Rep; 2022 Aug; 12(1):13766. PubMed ID: 35962042 [TBL] [Abstract][Full Text] [Related]
19. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048 [TBL] [Abstract][Full Text] [Related]
20. A novel ferroptosis-related gene signature associated with cuproptosis for predicting overall survival in breast cancer patients. Zhang X; Zhang Q Acta Biochim Pol; 2023 Nov; 70(4):875-884. PubMed ID: 37930188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]